FR0010609263 - Common Stock
MAUNA KEA TECHNOLOGIES
EPA:ALMKT (9/6/2024, 7:00:00 PM)
0.343
0 (-1.01%)
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 68 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE
P: 33148240345
Employees: 68
Website: https://www.maunakeatech.com/
Find more stocks on Euronext Paris - Matif
Find more stocks on the EuroNext
Find more stocks on the European
Find competitors from the same sector on the EuroNext
Find competitors from the same industry on the EuroNext
Find stocks with similar TA and Setup ratings on the EuroNext
Find stocks with similar Fundamental rating on the EuroNext
Find the competitors with the best technical ratings on the EuroNext
Find the competitors with the best technical and setup ratings on the EuroNext
Find the competitors with the best fundamentals on the EuroNext
Find the competitors with the best valuation on the EuroNext
Find the competitors with the best dividend on the EuroNext
Find the competitors with the best analyst ratings on the EuroNext